Maxim M. Osadchuk

Dr. Maxim M. Osadchuk


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in Therapy
Verified
Journal Article
Closed access
OOOsadchuk A.M. Osadchuk
Osadchuk A.M. Osadchuk
MOMaxim M. Osadchuk
Maxim M. Osadchuk
ZZZolotovskaya I.A. Zolotovskaya
Zolotovskaya I.A. Zolotovskaya
MRMoscow Russian Medical Academy Of Continuing Professional Education Of The Ministry Of Healthcare Of Russia
Moscow Russian Medical Academy Of Continuing Professional Education Of The Ministry Of Healthcare Of Russia
SRSamara State Medical University of the Ministry of Healthcare of Russia
Samara State Medical University of the Ministry of Healthcare of Russia

9 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MOMikhail A. Osadchuk
Mikhail A. Osadchuk
IVInna N. Vasil’Eva
Inna N. Vasil’Eva
IKIuliia Krylova
Iuliia Krylova
MOMaxim M. Osadchuk
Maxim M. Osadchuk
EMEkaterina D. Mironova
Ekaterina D. Mironova
Simon Bernard Iloki  AssangaSimon Bernard Iloki Assanga
Simon Bernard Iloki Assanga
The duodenal mucosa plays a pivotal role in gastrointestinal physiology through its endocrine cells (ECs), which secrete key regulatory factors including motilin (MLN), somatostatin (SS), and vascular endothelial growth factor (VEGF). Alterations in the expression of these mediators have been implicated in the pathogenesis of irritable bowel syndrome with constipation (IBS-C) and its overlap with functional dyspepsia (FD). In this study, immunohistochemical and morphometric analyses were performed on duodenal retrobulbar part biopsies obtained from patients with IBS-C, IBS-C combined with FD, and healthy controls. The results demonstrated a significant reduction in MLN-secreting ECs, accompanied by increased SS- and VEGF-positive ECs in IBS-C with FD patients compared to other groups. These endocrine alterations were associated with more severe abdominal pain, higher body mass index, and greater anxiety and depression scores. The findings highlight the contribution of duodenal EC dysfunction to impaired motility, visceral hypersensitivity, and low-grade inflammation, supporting the concept of the duodenum as a critical neuroendocrine hub within the gut–brain axis. This study underscores the relevance of MLN, SS, and VEGF as potential biomarkers and therapeutic targets in IBS-C and FD comorbidity.